Thailand Clinical Laboratory Services Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2021 –2028 |
 Market Size (Base Year) |
USD 3,419.06 Million |
 Market Size (Forecast Year) |
USD 5,484.69 Million |
 CAGR |
% |
| Major Markets Players |
Thailand Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Haematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing and Genetic Testing), Provider (Hospital-Based Laboratories, Independent and Reference Laboratories, Clinical-Based Laboratories, and Nursing and Physician Office-Based Laboratories), Application (Bioanalytical and Lab Chemistry Services, Drug Development Related Services, Drug Discovery Related Services, Toxicology Testing Services, Cell, and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services, and Other Clinical Laboratory Services), Country (Thailand) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Thailand Clinical Laboratory Services Market
Thailand clinical laboratory services market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Thailand clinical laboratory services market is growing with a CAGR of 6.2% in the forecast period of 2021 to 2028 and is expected to reach USD 5,484.69 million by 2028 from USD 3,419.06 million in 2020. The rising prevalence of infectious diseases and increasing awareness of early and accurate diagnosis are the major drivers that propelled the market's demand in the forecast period.
Clinical laboratories are an important part of the healthcare sector. Most diagnostic tests, starting from the blood test to the genetic analysis, are conducted in these clinical laboratories to detect diseases. Clinical laboratories offer data and resources that optimize the required distribution in the healthcare system, such as diagnostics and test results. This maintains and provides reliable and correct test results that enable doctors to make appropriate clinical and diagnostic decisions across various levels of health care services.
The increasing adoption of digital pathology has further propelled the demand for clinical laboratory services. The high prevalence of infectious diseases across Thailand and the increasing awareness of early and accurate diagnosis are likely to fuel the growth of the clinical laboratory services market. Moreover, inaccurate test results and reimbursement policies act as a challenge for the market. The strategic initiatives by market players and rising preventive health check-ups act as an opportunity for the market's growth. However, lack of skilled and certified professionals and stringent regulatory policies act as a restraint for its growth in the market.
The Thailand clinical laboratory services market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Thailand Clinical Laboratory Services Market Scope and Market Size
The Thailand clinical laboratory services market is segmented based on service type, specialty, provider, and application. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of service type, the Thailand clinical laboratory services market is segmented into routine testing services, esoteric services, and anatomic pathology services. In 2021, the routine testing services segment is expected to dominate the market due to the growing cases of chronic diseases such as liver diseases, cardiovascular diseases, and blood disorders.
- On the basis of specialty, the Thailand clinical laboratory services market is segmented into clinical chemistry testing, microbiology testing, haematology testing, genetic testing, drugs of abuse testing, and immunology testing. In 2021, the clinical chemistry testing segment is expected to dominate the market due to an increase in demand for point of care testing solutions, which are used for the fast diagnosis of the disease.
- On the basis of provider, the Thailand clinical laboratory services market is segmented into independent and reference laboratories, hospital-based laboratories, and nursing and physician office-based laboratories. In 2021, the hospital-based laboratories segment is expected to dominate the market due to increased cases of injuries in the hospitals, leading to high patient volumes and high test demand.
- On the basis of application, the Thailand clinical laboratory services market is segmented into drug discovery related services, drug development related services, bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, and other clinical laboratory services. In 2021, the bioanalytical and lab chemistry services segment is expected to dominate the market because bioanalysis is an important factor in drug discovery and development.
Growing Adoption of Digital Pathology Platforms and High Prevalence of Chronic Diseases in the Clinical Laboratory Services is Creating New Opportunities for Players in the Thailand Clinical Laboratory Services Market
Thailand clinical laboratory services market also provides you with a detailed market analysis of market sales, impact of advancement in the Thailand clinical laboratory services market, and changes in regulatory scenarios with their support for the Thailand clinical laboratory services market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Thailand Clinical Laboratory Services Market Share Analysis
Thailand clinical laboratory services market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company’s focus on the Thailand clinical laboratory services market.
The major players covered in the Thailand clinical laboratory services report are Eurofins Scientific, Siemens Healthcare GmbH, Abbott, Charles River Laboratories, Laboratory Corporation of America Holdings, Andalab Medical Laboratories, Brianet, SGS SA, and Syneos Health, among others and domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies that accelerate the Thailand clinical laboratory services market.
For instance,
- In June 2021, Eurofins Scientific announced that its subsidiary Eurofins Clinical Testing US Holdings, Inc. entered into an agreement to acquire Diagnostics Center (“DDC”), a leader in consumer genetic testing services. This Acquisition has benefitted the company in terms of expanding its testing services in consumer genetic testing
- In February 2021, Siemens Healthcare GmbH offered lab-based antigen tests for high-throughput analyzers and expanded COVID-19 test capacities. The company obtained CE Mark for its laboratory-based SARS-CoV-2 Antigen Assay (CoV2Ag); the test will be offered at the Atellica Solution and ADVIA Centaur analyzers, widely available in laboratories worldwide
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET BY SERVICE TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 THAILAND CLINICAL LABORATORY SERVICES MARKET CLINICAL LABORATORY SERVICES MARKET: REGULATIONS
5.1 REGULATIONS IN THAILAND
5.2 REGULATIONS IN PHILIPPINES
5.3 REGULATIONS IN MALAYSIA
5.4 REGULATION IN INDONESIA
6 REIMBURSEMENT SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES
7.1.2 ADVANCEMENTS IN CLINICAL DIAGNOSTIC METHODS
7.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
7.1.4 RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS
7.1.5 RISING PER CAPITA INCOME
7.2 RESTRAINTS
7.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
7.2.2 STRICT REGULATORY POLICIES
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF DIGITAL PATHOLOGY PLATFORMS
7.3.2 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
7.3.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
7.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 INACCURATE RESULTS OF TESTS
7.4.2 INADEQUATE REIMBURSEMENTS POLICIES
8 IMPACT OF COVID-19
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
9.1 OVERVIEW
9.2 ROUTINE TESTING SERVICES
9.2.1 ROUTINE CHEMISTRY TESTING
9.2.2 ROUTINE HEMATOLOGY TESTING
9.2.3 URINALYSIS TESTING
9.2.4 SUBSTANCE ABUSE TESTING
9.2.5 OTHERS
9.3 ESOTERIC SERVICES
9.4 ANATOMIC PATHOLOGY SERVICES
9.4.1 CYTOLOGY TESTING
9.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING
9.4.3 AUTOPSY PATHOLOGY
9.4.4 OTHERS
10 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
10.1 OVERVIEW
10.2 CLINICAL CHEMISTRY TESTING
10.2.1 ROUTINE CHEMISTRY TESTING
10.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING
10.2.3 SPECIALIZED CHEMISTRY TESTING
10.2.4 OTHER CLINICAL CHEMISTRY TESTING
10.3 HEMATOLOGY TESTING
10.3.1 ROUTINE HEMATOLOGY TESTING
10.3.2 SPECIALIZED HEMATOLOGY TESTING
10.3.3 COAGULATION TESTING
10.4 MICROBIOLOGY TESTING
10.4.1 INFECTIOUS DISEASE TESTING
10.4.2 TRANSPLANT DIAGNOSTIC TESTING
10.4.3 OTHER MICROBIOLOGY TESTING
10.5 IMMUNOLOGY TESTING
10.6 DRUGS OF ABUSE TESTING
10.7 CYTOLOGY TESTING
10.8 GENETIC TESTING
11 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
11.1 OVERVIEW
11.2 HOSPITAL-BASED LABORATORIES
11.3 INDEPENDENT & REFERENCE LABORATORIES
11.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES
12 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES
12.3 DRUG DEVELOPMENT RELATED SERVICES
12.4 DRUG DISCOVERY RELATED SERVICES
12.5 TOXICOLOGY TESTING SERVICES
12.6 CELL & GENE THERAPY RELATED SERVICES
12.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES
12.8 OTHER CLINICAL LABORATORY SERVICES
13 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY
13.1 THAILAND
14 THAILAND CLINICAL LABORATORY SERVICES MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: THAILAND
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 ANDALAB MEDICAL LABORATORIES
16.2.1 COMPANY SNAPSHOT
16.2.2 SERVICE PORTFOLIO
16.2.3 RECENT DEVELOPMENT
16.3 BRIANET
16.3.1 COMPANY SNAPSHOT
16.3.2 SERVICE PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4 CHARLES RIVER LABORATORIES
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 CITO CLINICAL LABORATORY
16.5.1 COMPANY SNAPSHOT
16.5.2 SERVICE PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 DAVITA INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 RECENT FINANCIALS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 EUROFINS SCIENTIFIC
16.7.1 COMPANY SNAPSHOT
16.7.2 RECENT FINANCIALS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 KERALTY
16.8.1 COMPANY SNAPSHOT
16.8.2 SERVICE PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 LABSERV INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 LABORATORY CORPORATION OF AMERICA® HOLDINGS
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 MAYON CLINICAL LABORATORIES
16.11.1 COMPANY SNAPSHOT
16.11.2 SERVICE PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 MEDI LINX LABORATORY, INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 QUEST DIAGNOSTICS INCORPORATED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SERVICE PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 PARAHITA DIAGNOSTIC CENTER
16.14.1 COMPANY SNAPSHOT
16.14.2 SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 PRODIA
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 PT KIMIA FARMA DIAGNOSTIKA
16.16.1 COMPANY SNAPSHOT
16.16.2 SERVICE PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 SGS SA
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENTS
16.18 SIEMENS HEALTHCARE GMBH
16.18.1 COMPANY SNAPSHOT
16.18.2 RECENT FINANCIALS
16.18.3 SERVICE PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 SUNWAY MED LAB
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 SYNEOS HEALTH
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 SERVICE PORTFOLIO
16.20.4 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS
TABLE 2 PRICE LIST OF VARIOUS HEMATOLOGY LABORATORY TESTINGS
TABLE 3 PRICE LIST OF VARIOUS SEROLOGY & IMMUNOLOGY LABORATORY TESTINGS
TABLE 4 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 5 THAILAND ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 6 THAILAND ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 7 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 8 THAILAND CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 9 THAILAND HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 10 THAILAND MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 11 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 12 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 14 THAILAND ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 15 THAILAND ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 16 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 17 THAILAND CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 18 THAILAND MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 19 THAILAND HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 20 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 21 THAILAND CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 THAILAND CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
FIGURE 2 THAILAND CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 THAILAND CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 THAILAND CLINICAL LABORATORY SERVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 THAILAND CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 THAILAND CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 THAILAND CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 THAILAND CLINICAL LABORATORY SERVICES MARKET SERVICE TYPE COVERAGE GRID
FIGURE 9 THAILAND CLINICAL LABORATORY SERVICES MARKET VENDOR SHARE ANALYSIS
FIGURE 10 THAILAND CLINICAL LABORATORY SERVICES MARKET SEGMENTATION
FIGURE 11 RISING INFECTIOUS DISEASES AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE GLOBAL CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE THAILAND CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028
FIGURE 13 REIMBURSEMENT POLICIES IN INDONESIA
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THAILAND CLINICAL LABORATORY SERVICES MARKET
FIGURE 15 BURDEN OF INFECTIOUS DISEASE IN SOUTHEAST ASIAN COUNTRIES
FIGURE 16 GROSS DOMESTIC PRODUCT (GDP) OF THE ASEAN COUNTRIES FROM 2000 TO 2018 (IN BILLION U.S. DOLLARS)
FIGURE 17 GDP PER CAPITA OF ASEAN COUNTRIES AS OF 2018
FIGURE 18 BENEFITS OF DIGITAL PATHOLOGY PLATFORMS
FIGURE 19 NUMBER OF COVID-19 TESTS IN SOUTHEAST ASIA AS OF 27 AUG, 2021
FIGURE 20 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020
FIGURE 21 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021-2028 (USD MILLION)
FIGURE 22 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2028)
FIGURE 23 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 24 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020
FIGURE 25 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2021-2028 (USD MILLION)
FIGURE 26 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, CAGR (2021-2028)
FIGURE 27 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, LIFELINE CURVE
FIGURE 28 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020
FIGURE 29 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2021-2028 (USD MILLION)
FIGURE 30 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, CAGR (2021-2028)
FIGURE 31 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 32 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020
FIGURE 33 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 34 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 35 THAILAND CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 36 THAILAND CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
